Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes

Stroke - United States
doi 10.1161/strokeaha.108.534107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2009English

Cholesterol Lowering for the Prevention of Stroke

Practical Neurology
MedicineNeurology
2003English

Cholesterol Lowering, Nutrition and Stroke Prevention

Canadian Journal of Neurological Sciences
MedicineNeurology
2012English

Stroke Prevention in Atrial Fibrillation Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

Primary Prevention of Stroke by Healthy Lifestyle

Circulation
Cardiovascular MedicinePhysiologyCardiology
2008English

Accuracy of Siriraj Stroke Scale in the Diagnosis of Stroke Subtypes Among Stroke Patients

International Journal of Research in Medical Sciences
2017English

Atorvastatin in Stroke: A Review of SPARCL and Subgroup Analysis

Vascular Health and Risk Management
2010English

Stroke Prevention

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1995English

Association of Optimal Combination Drug Treatment With Obesity Status Among Recent Ischemic Stroke Patients: Results of the Vitamin Intervention for Stroke Prevention (VISP) Trial

Journal of Stroke
NeurologyCardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy